Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and gatekeeper features https://www.medrxiv.org/content/10.1101/2022.11.15.22282201
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.